Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is associated with coronary artery plaque calcification as assessed by intravascular ultrasound
M Pfohl,
A Athanasiadis,
M Koch,
P Clemens,
N Benda,
HU Haring,
and
KR Karsch
Department of Medicine, University of Tubingen, Germany. martin.pfohl@t-online.de
OBJECTIVES: We evaluated the influence of the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene on coronary plaque morphology and calcification in patients with angiographically documented coronary artery disease (CAD). BACKGROUND: The ACE I/D polymorphism has been associated with an increased risk of myocardial infarction in patients with the DD genotype but not with the presence of native CAD. METHODS: We studied 146 patients undergoing percutaneous transluminal coronary angioplasty for stable angina pectoris by means of preinterventional intravascular ultrasound (IVUS). Qualitative and quantitative criteria were used to classify the target lesions as poorly or highly echoreflective or as calcified. Genomic deoxyribonucleic acid was analyzed by polymerase chain reaction (PCR) to identify the I/D polymorphism, with a second insertion-specific PCR in DD genotypes to prevent mistyping. RESULTS: The ACE genotype groups (DD 46, ID 68, II 32) were well matched for the basic characteristics. Patients with the DD genotype had significantly more calcified lesions (DD 80%, ID 57%, II 66%; unadjusted odds ratio [OR] 2.88, 95% confidence interval [CI] 1.30 to 6.92, p = 0.008) and more calcifications >180 degrees of the vessel circumference (DD 22%, ID 10%, II 6%; OR 2.80, 95% CI 1.05 to 7.63, p = 0.03). The prevalence of myocardial infarction was not significantly associated with coronary calcification (OR 1.44, 95% CI 0.72 to 2.88, p = 0.31). CONCLUSIONS: Patients with CAD and the ACE DD genotype have a significantly higher incidence and greater extent of coronary lesion calcification, as determined by IVUS. This finding indicates that the ACE I/D gene polymorphism is related to the development or progression of atherosclerotic plaque calcification.
This article has been cited by other articles:

|
 |

|
 |
 
B. Weijs, Y. Blaauw, R. J. M. W. Rennenberg, L. J. Schurgers, C. C. M. M. Timmermans, L. Pison, R. Nieuwlaat, L. Hofstra, A. A. Kroon, J. Wildberger, et al.
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
Eur. Heart J.,
October 2, 2011;
32(20):
2555 - 2562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Koulaouzidis and M. Henein
Coronary Calcification and Hormones
Angiology,
October 1, 2011;
62(7):
554 - 564.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rutsch, Y. Nitschke, and R. Terkeltaub
Genetics in Arterial Calcification: Pieces of a Puzzle and Cogs in a Wheel
Circ. Res.,
August 19, 2011;
109(5):
578 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman
ACE Polymorphisms
Circ. Res.,
May 12, 2006;
98(9):
1123 - 1133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev.,
August 1, 2004;
25(4):
629 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Burke, R. Virmani, Z. Galis, C. C. Haudenschild, and J. E. Muller
Task force #2--what is the pathologic basis for new atherosclerosis imaging techniques?
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
1874 - 1886.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Peyser, L. F. Bielak, J. S. Chu, S. T. Turner, D. L. Ellsworth, E. Boerwinkle, and P. F. Sheedy II
Heritability of Coronary Artery Calcium Quantity Measured by Electron Beam Computed Tomography in Asymptomatic Adults
Circulation,
July 16, 2002;
106(3):
304 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. O'Donnell, I. Chazaro, P. W.F. Wilson, C. Fox, M. T. Hannan, D. P. Kiel, and L. A. Cupples
Evidence for Heritability of Abdominal Aortic Calcific Deposits in the Framingham Heart Study
Circulation,
July 16, 2002;
106(3):
337 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Lange, E. M. Lange, L. F. Bielak, C. D. Langefeld, S. L. Kardia, P. Royston, S. T. Turner, P. F. Sheedy II, E. Boerwinkle, and P. A. Peyser
Autosomal Genome-Wide Scan for Coronary Artery Calcification Loci in Sibships at High Risk for Hypertension
Arterioscler Thromb Vasc Biol,
March 1, 2002;
22(3):
418 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Wagenknecht, D. W. Bowden, J. J. Carr, C. D. Langefeld, B. I. Freedman, and S. S. Rich
Familial Aggregation of Coronary Artery Calcium in Families With Type 2 Diabetes
Diabetes,
April 1, 2001;
50(4):
861 - 866.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Pfohl, M. Koch, S. Prescod, K.K. Haase, H.U. Haring, and K.R. Karsch
Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study
Eur. Heart J.,
September 2, 1999;
20(18):
1318 - 1325.
[Abstract]
[PDF]
|
 |
|
|